Proud to be Here: Declining Rates of Dementia and EPO-Agents for Anemia in Kidney Disease
This week, Amol, general internal medicine resident at the University of Toronto, and Fahad, staff internist at St. Michael’s Hospital in Toronto, discuss 2 recent papers:
Is dementia in decline? A study using the well-characterized Framingham cohort found that dementia rates in the last four decades have declined by 20%. Fahad evaluate the quality of this data, and the generalizability of the Framingham cohort to the global population. For a discussion about healthcare costs in dementia, check out our “Cognition Edition” episode.
Existing guidelines recommend using erythropoietin stimulating agents to treat anemia in chronic kidney disease. However, a systematic review and meta analysis found that erythropoietin stimulating agents didn’t improve patients’ health related quality of life. Given the heterogeneity of the studies included, how robust is this result?
Rate us on iTunes and follow us on Twitter @roundstable!
1. Incidence of dementia: http://www.nejm.org/doi/full/10.1056/NEJMoa1504327
2. EPO-agents for anemia in kidney disease: http://annals.org/article.aspx?articleid=2491918
Music Credits (Creative Commons)
In your Robotic Heart – Nicolai Heidlas https://soundcloud.com/nicolai-heidlas/in-your-robotic-heart
Drive – Nicolai Heidlas https://soundcloud.com/nicolai-heidlas/drive-fresh-upbeat-pop-background-music
Vintage Dream – Nicolai Heidlas https://soundcloud.com/nicolai-heidlas/vintage-dream-loungejazzy-background-music
All tracks have been modified for the purposes of this podcast.